Skip to the page

Data / Form D filings / Superior Genomics, Inc.

Superior Genomics, Inc.: Form D filing

Superior Genomics, Inc., a technology company in Norway, MI, filed a Form D with the SEC in 2026. The latest, on August 14, 2026, reports $507,500 sold of a $1.5 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
640 MAIN ST, Norway, MI, 49870
Phone
(906) 221-1001
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2148532

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 14, 2026New notice$1,500,000$507,500$992,50014Jul 30, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David Van HollaExecutive Officer, Director
John Prista FreshleyDirector

Other technology companies in Michigan that filed recently

Every Form D from the week of Aug 10, 2026 · All recent filings in Michigan · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Superior Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.